PTHvsLFSCETF Comparison
VS
Invesco DWA Healthcare Momentum ETF (PTH) belongs to the US Health Care segment. F/m Emerald Life Sciences Innovation ETF (LFSC) is part of the Life Sciences segment. Both ETFs have the same top 3 sector exposures: and Healthcare. PTH is less expensive with a Total Expense Ratio (TER) of 0.72%, versus 0.79% for LFSC. PTH is up 17.82% year-to-date (YTD) with +$88M in YTD flows. LFSC performs better with 23.23% YTD performance, and +$8M in YTD flows. Run a side-by-side ETF comparison of PTH and LFSC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PTH vs LFSC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PTH LFSC | +5.19%+4.17% | +12.36%+20.39% | +17.82%+23.23% | +58.30%+82.30% | +56.89%n/a | +7.61%n/a |
| Flows | PTH LFSC | +$102M+$2M | +$94M+$3M | +$88M+$8M | +$92M+$17M | +$25M- | -$192M- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PTH LFSC | +29.53%+26.23% | +24.63%+26.91% | +25.60%n/a | +25.58%n/a |
| Max drawdown | PTH LFSC | -8.31%-6.53% | -11.91%-16.25% | -27.71%n/a | -50.10%n/a |
| Max drawdown duration | PTH LFSC | 41d20d | 140d168d | 353dn/a | 1756dn/a |
Trading data
PTH | LFSC | |
Last sale 7/24/2026 at 1:30 PM | $58.57 | $45.10 |
| Previous close 07/23/2026 | $59.39 | $45.46 |
| Consolidated volume 07/23/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
LFSC
is actively managed and doesn’t replicate an indexPTH | LFSC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/24/2026 at 1:30 PM
Live
Closed
PTH | LFSC | |
|---|---|---|
| Last price | $58.57 | $45.10 |
| 1D performance | -1.38% | -0.79% |
| AuM | $231.95 M | $123.48 M |
| E/R | 0.72% | 0.79% |
Characteristics
PTH | LFSC | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Invesco | Emerald Group |
| Benchmark | Dorsey Wright Healthcare Technical Leaders Index | - |
| N° of holdings | 57 | 40 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 12, 2006 | October 31, 2024 |
| ESG | No | No |
Advertisement
Exposure
Countries
PTH
USA
92.25%
Other
7.75%
LFSC
USA
90.9%
United Kingdom
7.04%
Other
2.06%
Sectors
PTH
Healthcare
100%
Other
0%
LFSC
Healthcare
98.03%
Other
1.97%
Advertisement
Diversification
PTH
Total weight of top 15 holdings out of 15
43.88%
LFSC
Total weight of top 15 holdings out of 15
73.24%
Top 15 holdings
Data as of June 30, 2026
PTH
Roivant Sciences Ltd.
4.95%
Praxis Precision Medicines, Inc.
4.66%
Tango Therapeutics, Inc.
3.70%
SELLAS Life Sciences Group, Inc.
3.36%
United Therapeutics Corp.
2.91%
Tenet Healthcare Corp.
2.89%
Axsome Therapeutics, Inc.
2.74%
BrightSpring Health Services, Inc.
2.54%
Liquidia Corp.
2.52%
Moderna, Inc.
2.49%
Ionis Pharmaceuticals, Inc.
2.30%
Erasca, Inc.
2.29%
HCA Healthcare, Inc.
2.23%
Twist Bioscience Corp.
2.21%
Protagonist Therapeutics, Inc.
2.08%
LFSC
Travere Therapeutics, Inc.
8.37%
Cogent Biosciences, Inc.
7.18%
LivaNova Plc
7.04%
Spyre Therapeutics, Inc.
6.71%
Guardant Health, Inc.
5.56%
Corcept Therapeutics, Inc.
5.27%
Mirum Pharmaceuticals, Inc.
5.25%
BillionToOne, Inc.
4.25%
Cytokinetics, Inc.
4.13%
Veradermics, Inc.
3.76%
United Therapeutics Corp.
3.55%
Trevi Therapeutics, Inc.
3.50%
Savara, Inc.
3.20%
Dianthus Therapeutics, Inc.
2.77%
Nektar Therapeutics
2.70%
Frequently asked questions about PTH and LFSC
How have the PTH and LFSC ETFs performed in 2026?
As of July 24, 2026, PTH is up 17.82% year-to-date (YTD), while LFSC has returned 23.23%. That puts LFSC better performer ahead so far this year.
Which ETF is attracting more investor money: PTH or LFSC?
Year-to-date, the PTH ETF saw +$88M in flows, compared to +$8M for LFSC.
Which ETF is more volatile: PTH or LFSC?
Over the past year, PTH had a volatility of 24.63%, while LFSC experienced 26.91%.
Which ETF is bigger: PTH or LFSC?
As of July 24, 2026, PTH holds $231.95 M in assets under management (AUM), while LFSC manages $123.48 M.
What sectors do the PTH and LFSC ETFs invest in?
PTH leans toward sectors like Healthcare. Meanwhile, LFSC focuses on Healthcare.
What are the top holdings of the PTH ETF and LFSC ETF?
PTH top holdings include Roivant Sciences Ltd., Praxis Precision Medicines, Inc. and Tango Therapeutics, Inc.. LFSC holds in its top three: Travere Therapeutics, Inc., Cogent Biosciences, Inc. and LivaNova Plc.
Which ETF is more diversified: PTH or LFSC?
PTH holds 57 securities with 43.88% of its assets in the top 15. LFSC has 40 securities and a top 15 weight of 73.24%.
Advertisement
Latest news about PTH & LFSC
Advertisement
